These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32161460)

  • 1. Synergistic Treatment of Tumor by Targeted Biotherapy and Chemotherapy via Site-Specific Anchoring of Aptamers on DNA Nanotubes.
    Chen R; Sun P; Chu X; Pu X; Yang Y; Zhang N; Zhao Y
    Int J Nanomedicine; 2020; 15():1309-1320. PubMed ID: 32161460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin.
    Yao F; An Y; Li X; Li Z; Duan J; Yang XD
    Int J Nanomedicine; 2020; 15():2119-2129. PubMed ID: 32280210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrP
    Go G; Lee CS; Yoon YM; Lim JH; Kim TH; Lee SH
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembly of DNA nanostructure containing cell-specific aptamer as a precise drug delivery system for cancer therapy in non-small cell lung cancer.
    Wang N; Yu C; Xu T; Yao D; Zhu L; Shen Z; Huang X
    J Nanobiotechnology; 2022 Nov; 20(1):486. PubMed ID: 36403038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy.
    Zhao N; Zeng Z; Zu Y
    Small; 2018 Jan; 14(4):. PubMed ID: 29205808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Assembled DNA-Protein Hybrid Nanospheres: Biocompatible Nano-Drug-Carriers for Targeted Cancer Therapy.
    Lee D; Baek S; Kim YY; Bang Y; Jung HN; Im HJ; Song YK
    ACS Appl Mater Interfaces; 2022 Aug; 14(33):37493-37503. PubMed ID: 35969502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells.
    Luo X; Yang Y; Kong F; Zhang L; Wei K
    Int J Pharm; 2019 Jun; 564():340-349. PubMed ID: 31002934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
    Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
    J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
    Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
    Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer.
    Xu W; Siddiqui IA; Nihal M; Pilla S; Rosenthal K; Mukhtar H; Gong S
    Biomaterials; 2013 Jul; 34(21):5244-53. PubMed ID: 23582862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-responsive DNA nanomicelles for chemo-gene synergetic therapy of anaplastic large cell lymphoma.
    Li Y; Yue S; Cao J; Zhu C; Wang Y; Hai X; Song W; Bi S
    Theranostics; 2020; 10(18):8250-8263. PubMed ID: 32724469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells.
    Zhou G; Da Won Bae S; Nguyen R; Huo X; Han S; Zhang Z; Hebbard L; Duan W; Eslam M; Liddle C; Yuen L; Lam V; Qiao L; George J
    Cancer Lett; 2021 Mar; 501():124-132. PubMed ID: 33352247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway.
    Ye BL; Zheng R; Ruan XJ; Zheng ZH; Cai HJ
    Biochem Biophys Res Commun; 2018 Jan; 495(1):414-420. PubMed ID: 29097204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
    Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
    Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific anchoring aptamer C2NP on DNA origami nanostructures for cancer treatment.
    Sun P; Zhang N; Tang Y; Yang Y; Zhou J; Zhao Y
    RSC Adv; 2018 Jul; 8(46):26300-26308. PubMed ID: 35541930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.
    Xiao Y; Jaskula-Sztul R; Javadi A; Xu W; Eide J; Dammalapati A; Kunnimalaiyaan M; Chen H; Gong S
    Nanoscale; 2012 Nov; 4(22):7185-93. PubMed ID: 23070403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinspired DNA nanocockleburs for targeted delivery of doxorubicin.
    Sun S; Cheraga N; Jiang HN; Xiao QR; Gao PC; Wang Y; Wei YY; Wang XW; Jiang Y
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110733. PubMed ID: 31864113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.